When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Colorectal Cancer: Screening - United States Preventive Services...

    www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer...

    In 2017, the US Multi-Society Task Force recommended beginning screening at age 45 years in Black adults (weak recommendation) and screening at age 40 years (or 10 years before the age at diagnosis of a family member, whichever is earlier) in persons with a family history for colorectal cancer.

  3. Screening for Colorectal Cancer: Recommendation Statement - AAFP

    www.aafp.org/pubs/afp/issues/2017/0215/od1.html

    There are numerous screening tests to detect early-stage colorectal cancer, including stool-based tests (gFOBT, FIT, and FIT-DNA), direct visualization tests (flexible sigmoidoscopy, alone or...

  4. USPSTF Recommendation: Screening for Colorectal Cancer

    jamanetwork.com/journals/jama/fullarticle/2779985

    In 2017, the US Multi-Society Task Force recommended beginning screening at age 45 years in Black adults (weak recommendation) and screening at age 40 years (or 10 years before the age at diagnosis of a family member, whichever is earlier) in persons with a family history for colorectal cancer.

  5. Colorectal Cancer: Screening - United States Preventive Services...

    www.uspreventiveservicestaskforce.org/.../colorectal-cancer-screening

    The USPSTF expanded the recommended ages for colorectal cancer screening to 45 to 75 years (previously, it was 50 to 75 years). The USPSTF continues to recommend selectively screening adults aged 76 to 85 years for colorectal cancer.

  6. U.S. Preventive Services Task Force Issues Final Recommendation...

    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/...

    These final recommendations all apply to adults without symptoms and who do not have a personal history of colorectal polyps or a personal or family health history of genetic disorders that increase the risk of colorectal cancer. Colorectal cancer is the third leading cause of cancer deaths in the United States.

  7. USPSTF Recommendation Statement: Screening for Colorectal Cancer

    jamanetwork.com/journals/jama/fullarticle/2529486

    A positive family history (excluding known inherited familial syndromes) is thought to be linked to about 20% of cases of colorectal cancer. 1 About 3% to 10% of the population has a first-degree relative with colorectal cancer. 7 The USPSTF did not specifically review the evidence on screening in populations at increased risk; however, other ...

  8. Screening for Colorectal Cancer: Summary of 2021 U.S. Preventive...

    www.asge.org/docs/default-source/default-document-library/uspsft_guideline...

    Obtain detailed family history to identify those with hereditary CRC syndromes How to screen? The USPSTF recommends the following screening strategies as acceptable:

  9. USPSTF Review: Screening for Colorectal Cancer - JAMA Network

    jamanetwork.com/journals/jama/fullarticle/2779987

    Analytic Framework: Screening for Colorectal Cancer. Evidence reviews for the US Preventive Services Task Force (USPSTF) use an analytic framework to visually display the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety of a preventive service.

  10. Screening for Colorectal Cancer | Colorectal Cancer | CDC

    www.cdc.gov/colorectal-cancer/screening

    Colorectal cancer almost always develops from precancerous polyps (abnormal growths) in the colon or rectum. Screening tests can find precancerous polyps, so that they can be removed before they turn into cancer. Screening tests can also find colorectal cancer early, when treatment works best.

  11. Screening for Colorectal Cancer - United States Preventive...

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/xL4XwcPKXBfTWgY5ouzLzy

    The USPSTF expanded the recommended ages for colorectal cancer screening to 45 to 75 years (previously, it was 50 to 75 years). The USPSTF continues to recommend selectively screening adults aged 76 to 85 years